BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8753015)

  • 1. [The characteristics of clinical features of pulmonary tuberculosis in female].
    Matsushita Y; Ikeda N; Kurasawa T; Sato A; Nakatani K; Inoue T; Ikeda T; Sakatani M; Kobayashi C; Ozawa S; Kanai K; Suruta N
    Kekkaku; 1996 Jun; 71(6):391-8. PubMed ID: 8753015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study of non-tuberculous pulmonary mycobacteriosis].
    Kurasawa T; Ikeda N; Sato A; Nakatani K; Matsusita Y; Inoue T; Sakatani M; Kobayashi C; Sunda N; Kanai K
    Kekkaku; 1995 Nov; 70(11):621-8. PubMed ID: 8656586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical comparison of active primary tuberculosis in recent years and the past].
    Fujino T; Watanabe S
    Kekkaku; 1991 Dec; 66(12):829-38. PubMed ID: 1784100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone and joint tuberculosis concurrent with tuberculosis of other organs].
    Yagi O; Kawabe Y; Nagayama N; Shimada M; Kawashima M; Kaneko Y; Ariga H; Ohshima N; Matsui Y; Suzuki J; Masuda K; Tamura A; Nagai H; Akagawa S; Machida K; Kurashima A; Nakajima Y; Yotsumoto H
    Kekkaku; 2007 Jun; 82(6):523-9. PubMed ID: 17633120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiologic study of the actual investigation of chronic excretors of Mycobacterium tuberculosis bacilli].
    Tsuchiya T; Kondo A; Sakatani M
    Kekkaku; 1996 Jan; 71(1):31-6. PubMed ID: 8808266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
    Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
    Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Actual status of the management of tuberculosis patients in a university hospital without isolation wards for infectious diseases].
    Kako K; Sakakibara H; Satou M; Kamidaira T; Suetsugu S
    Kekkaku; 1997 Jun; 72(6):395-401. PubMed ID: 9248273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients.
    Feleke Y; Abdulkadir J; Aderaye G
    East Afr Med J; 1999 Jul; 76(7):361-4. PubMed ID: 10520361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency of complication of diabetes mellitus in pulmonary tuberculosis].
    Yamagishi F; Sasaki Y; Yagi T; Yamatani H; Kuroda F; Shoda H
    Kekkaku; 2000 Jun; 75(6):435-7. PubMed ID: 10918789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A survey of the initial course of tuberculosis chemotherapy under compulsory hospitalization on the basis of the revised Tuberculosis Prevention Law--report of the 32nd C series of controlled trials of chemotherapy--Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanatoria in Japan].
    Sato K; Mori M; Katayama T; Haga T
    Kekkaku; 1993 Jul; 68(7):487-93. PubMed ID: 8361117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the changes in clinical features of tuberculosis].
    Toyoda T
    Kekkaku; 1990 Oct; 65(10):619-31. PubMed ID: 2259054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC11A1 (formerly NRAMP1) polymorphisms associated with multidrug-resistant tuberculosis.
    Takahashi K; Hasegawa Y; Abe T; Yamamoto T; Nakashima K; Imaizumi K; Shimokata K
    Tuberculosis (Edinb); 2008 Jan; 88(1):52-7. PubMed ID: 17950034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired anti-tuberculosis drug resistance in Yaounde, Cameroon.
    Kuaban C; Bercion R; Jifon G; Cunin P; Blackett KN
    Int J Tuberc Lung Dis; 2000 May; 4(5):427-32. PubMed ID: 10815736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nontuberculous mycobacteriosis; the present status of epidemiology and clinical studies].
    Sakatani M
    Kekkaku; 1999 Apr; 74(4):377-84. PubMed ID: 10355224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The causes of death in patients with non-MDR pulmonary tuberculosis in our hospital].
    Nagayama N; Masuda K; Takada W; Baba M; Hori A; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A
    Kekkaku; 2001 Jan; 76(1):1-8. PubMed ID: 11211778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection and antituberculosis drug resistance among pulmonary tuberculosis patients in Harar Tuberculosis Centre, Ethiopia.
    Mitike G; Kebede D; Yeneneh H
    East Afr Med J; 1997 Mar; 74(3):154-7. PubMed ID: 9185411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.